Cargando…
Fecal Capsule as a Therapeutic Strategy in IgA Nephropathy: A Brief Report
In this brief report, we reported an IgA nephropathy (IgAN) patient who presented in November 2020 with an acute exacerbation with massive proteinuria and diarrhea. He had the earliest onset in 2018 when his IgAN was diagnosed by renal biopsy. He has been treated with active ACEI/ARB drugs for more...
Autores principales: | Zhi, Wenqiang, Song, Wenzhu, Abdi Saed, Yasin, Wang, Yi, Li, Yafeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133370/ https://www.ncbi.nlm.nih.gov/pubmed/35647000 http://dx.doi.org/10.3389/fmed.2022.914250 |
Ejemplares similares
-
Landscape of intestinal microbiota in patients with IgA nephropathy, IgA vasculitis and Kawasaki disease
por: Hu, Xueli, et al.
Publicado: (2022) -
As Signals From the Kawasaki-Like Illness During the COVID-19 Pandemic: Is It Possible That the Incidence of IgA Nephropathy May Increase in the Future
por: Abdi Saed, Yasin, et al.
Publicado: (2021) -
Gut Microbes in Immunoglobulin A Nephropathy and Their Potential Therapeutic Applications
por: Wang, Yi, et al.
Publicado: (2022) -
Fecal Microbiota Transplantation May Represent a Good Approach for Patients with Focal Segmental Glomerulosclerosis: A Brief Report
por: Zhi, Wenqiang, et al.
Publicado: (2022) -
Effectiveness and safety of KunXian capsule for the treatment of IgA nephropathy
por: Le, Wei-Bo, et al.
Publicado: (2022)